Clincosm LogoSign in Get a demo

GnRH Agonist and Intrauterine Insemination

Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA (Other)
Overall Status
Completed
CT.gov ID
NCT00503217
Collaborator
(none)
1
Location
33.9
Duration (Months)

Study Details

Study Description

Brief Summary

The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Official Title:
Effect of GnRH Agonist Administration at the Time of Implantation in Intrauterine Insemination Cycles: A Randomized Controlled Trial
Study Start Date :
Feb 1, 2005
Actual Primary Completion Date :
Dec 1, 2007
Actual Study Completion Date :
Dec 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 38 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Women < 38 years old

    • Bilateral tubal patency confirmed by hysterosonography

    • Normal ultrasound scan of uterus and ovaries

    • Normal day 3 basal hormones

    • Motile sperm count after capacitation ≥ 3 mill/ml

    Exclusion Criteria:

    • Endometriosis

    • Polycystic ovary syndrome

    • Uterine disease (polyps, myomas and müllerian diseases)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Instituto Valenciano de Infertilidad Spain Valencia Spain 46015

    Sponsors and Collaborators

    • Instituto Valenciano de Infertilidad, IVI VALENCIA

    Investigators

    • Principal Investigator: Jose Bellver, MD, Instituto Valenciano de la Infertilidad
    • Principal Investigator: Elena Labarta, MD, Instituto Valenciano de Infertilidad

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jose Bellver, Gynecologist IVI Valencia, Instituto Valenciano de Infertilidad, IVI VALENCIA
    ClinicalTrials.gov Identifier:
    NCT00503217
    Other Study ID Numbers:
    • VLC-JB-0205-307-9
    First Posted:
    Jul 18, 2007
    Last Update Posted:
    Sep 7, 2016
    Last Verified:
    Sep 1, 2016
    Keywords provided by Jose Bellver, Gynecologist IVI Valencia, Instituto Valenciano de Infertilidad, IVI VALENCIA
    intrauterine insemination
    GnRH agonist
    implantation

    Study Results

    No Results Posted as of Sep 7, 2016